To test the effect of TSD+LT on peripheral inflammatory markers associates with treatment resistant depression, in a proof-of-concept study here we studied Interleukin-1β (IL-1β), which has been consistently associated with non-response to drugs (Arteaga-Henriquez et al., 2019; Benedetti et al., 2021). This evidence concerns the gene IL1B and depressive symptom measurement.